AU2002224810A1 - Nucleus export reporter system - Google Patents

Nucleus export reporter system

Info

Publication number
AU2002224810A1
AU2002224810A1 AU2002224810A AU2481002A AU2002224810A1 AU 2002224810 A1 AU2002224810 A1 AU 2002224810A1 AU 2002224810 A AU2002224810 A AU 2002224810A AU 2481002 A AU2481002 A AU 2481002A AU 2002224810 A1 AU2002224810 A1 AU 2002224810A1
Authority
AU
Australia
Prior art keywords
nucleus
transcript
rna export
exported
export
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002224810A
Other languages
English (en)
Inventor
Marcus Graf
Ralf Wagner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thermo Fisher Scientific Geneart GmbH
Original Assignee
Geneart AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geneart AG filed Critical Geneart AG
Publication of AU2002224810A1 publication Critical patent/AU2002224810A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1051Gene trapping, e.g. exon-, intron-, IRES-, signal sequence-trap cloning, trap vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1075Isolating an individual clone by screening libraries by coupling phenotype to genotype, not provided for in other groups of this subclass
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00Vectors comprising a special translation-regulating system
    • C12N2840/44Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Purification Treatments By Anaerobic Or Anaerobic And Aerobic Bacteria Or Animals (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Luminescent Compositions (AREA)
AU2002224810A 2000-10-30 2001-10-30 Nucleus export reporter system Abandoned AU2002224810A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10053781A DE10053781B4 (de) 2000-10-30 2000-10-30 Kernexportreportersystem
DE10053781.2 2000-10-30
PCT/EP2001/012534 WO2002036791A2 (fr) 2000-10-30 2001-10-30 Systeme reporteur d'exporation de noyau

Publications (1)

Publication Number Publication Date
AU2002224810A1 true AU2002224810A1 (en) 2002-05-15

Family

ID=7661567

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002224810A Abandoned AU2002224810A1 (en) 2000-10-30 2001-10-30 Nucleus export reporter system

Country Status (7)

Country Link
US (1) US7767455B2 (fr)
EP (4) EP2000546A1 (fr)
AT (1) ATE419386T1 (fr)
AU (1) AU2002224810A1 (fr)
DE (2) DE10053781B4 (fr)
ES (1) ES2316490T3 (fr)
WO (1) WO2002036791A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE502005008794D1 (de) 2004-08-03 2010-02-11 Geneart Ag Verfahren zur modulation der genexpression durch änderung des cpg gehalts
DE102004037611B4 (de) * 2004-08-03 2013-10-02 Geneart Ag Induzierbare Genexpression
AU2011230619C1 (en) 2010-03-25 2016-06-23 Oregon Health & Science University CMV glycoproteins and recombinant vectors
LT2691530T (lt) 2011-06-10 2018-08-10 Oregon Health & Science University Cmv glikoproteinai ir rekombinantiniai vektoriai

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU728422B2 (en) * 1996-06-21 2001-01-11 Merck & Co., Inc. Vaccines comprising synthetic genes
US6024965A (en) * 1996-10-18 2000-02-15 Erasums University Rotterdam Induction of REV and TAT specific cytotoxic T-cells for prevention and treatment of human immunodeficiency virus (HIV) infection
WO1999002694A1 (fr) * 1997-07-09 1999-01-21 The University Of Queensland Sequence d'acides nucleiques et procede pour exprimer, de maniere selective, une proteine dans une cellule ou un tissu cible
US6136597A (en) * 1997-09-18 2000-10-24 The Salk Institute For Biological Studies RNA export element
DE10130155B3 (de) * 2001-06-22 2004-03-04 GSF-Forschungszentrum für Umwelt und Gesundheit GmbH Reportergen-Konstrukt zum Nachweis von HIV-Rev und HIV-Tat

Also Published As

Publication number Publication date
EP2292791A1 (fr) 2011-03-09
EP2292790A1 (fr) 2011-03-09
EP1356111B1 (fr) 2008-12-31
ATE419386T1 (de) 2009-01-15
US20040087012A1 (en) 2004-05-06
DE50114629D1 (de) 2009-02-12
EP2000546A1 (fr) 2008-12-10
EP1356111A2 (fr) 2003-10-29
US7767455B2 (en) 2010-08-03
ES2316490T3 (es) 2009-04-16
DE10053781A1 (de) 2002-05-08
DE10053781B4 (de) 2008-07-03
WO2002036791A3 (fr) 2003-07-24
WO2002036791A2 (fr) 2002-05-10

Similar Documents

Publication Publication Date Title
Zufferey et al. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors
Donello et al. Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element
de Villiers et al. A small segment of polyoma virus DNA enhances the expression of a cloned β-globin gene over a distance of 1400 base pairs
Farnet et al. Integration of human immunodeficiency virus type 1 DNA in vitro.
Dubensky Jr et al. Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer
Ahmadian et al. Expression of the ORF-2 protein of the human respiratory syncytial virus M2 gene is initiated by a ribosomal termination-dependent reinitiation mechanism
Butsch et al. The 5′ RNA terminus of spleen necrosis virus contains a novel posttranscriptional control element that facilitates human immunodeficiency virus Rev/RRE-independent Gag production
Aiyar et al. The plasmid replicon of EBV consists of multiple cis‐acting elements that facilitate DNA synthesis by the cell and a viral maintenance element
Xu et al. Synthesis of a novel hepatitis C virus protein by ribosomal frameshift
KR920703801A (ko) 리보자임 조성물 및 그 사용방법
Woolaway et al. The 5′ untranslated region of Rhopalosiphum padi virus contains an internal ribosome entry site which functions efficiently in mammalian, plant, and insect translation systems
Stehle et al. Exploiting a minimal system to study the epigenetic control of DNA replication: the interplay between transcription and replication
NO995382D0 (no) Lentivirus baserte genoverföringsvektorer
CA2304207A1 (fr) Element de transport d'arn et procedes d'utilisation
NO20001497L (no) Ekspresjon av endogene gener ved ikke-homolog rekombinasjon av en vektorkonstrukt med cellulært DNA
EP0702716A4 (fr) Therapie genique ribozymique contre l'infection par le vih et contre le sida
Liljeström et al. Expression of proteins using Semliki Forest virus vectors
Plon et al. Transcription of the human β-globin gene is stimulated by an SV40 enhancer to which it is physically linked but topologically uncoupled
Deffaud et al. Rous sarcoma virus translation revisited: characterization of an internal ribosome entry segment in the 5′ leader of the genomic RNA
Kasher et al. Rapid enrichment of HeLa transcription factors IIIB and IIIC by using affinity chromatography based on avidin-biotin interactions
Pogue et al. 5'sequences of rubella virus RNA stimulate translation of chimeric RNAs and specifically interact with two host-encoded proteins
AU2002224810A1 (en) Nucleus export reporter system
CN109706172B (zh) 一种基于Alu元件的精准型环形RNA表达框架和载体及其应用
Otero et al. Splicing-independent expression of the herpes simplex virus type 1 thymidine kinase gene is mediated by three cis-acting RNA subelements
Hamelin et al. Temperature-sensitive viral RNA expression in Moloney murine sarcoma virus ts110-infected cells